Brazil Oligonucleotide Synthesis Market Size & Outlook
The oligonucleotide synthesis market in Brazil is expected to reach a projected revenue of US$ 208.1 million by 2033. A compound annual growth rate of 14.6% is expected of Brazil oligonucleotide synthesis market from 2026 to 2033.
Thermo Fisher Scientific Inc, Merck KGaA, GE HealthCare Technologies Inc Common Stock, Agilent Technologies, Kaneka Corp, Heritage Global Inc, Twist Bioscience Corp, Bio-Synthesis, Biolegio
Other key industry trends
In terms of revenue, Brazil accounted for 2.0% of the global oligonucleotide synthesis market in 2025.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
In Latin America, Brazil oligonucleotide synthesis market is projected to lead the regional market in terms of revenue in 2033.
Brazil is the fastest growing regional market in Latin America and is projected to reach USD 208.1 million by 2033.
The demand for oligonucleotides is expected to surge due to the expansion of the biotechnology and pharmaceutical sectors. The biotech and pharmaceutical industries in Brazil drive the need for custom oligonucleotides in research, diagnostics, and therapeutic applications.
Oligonucleotides are crucial in genetic research, including genomics, transcriptomics, and molecular diagnostics. As scientific research and genetic studies continue to expand, the demand for custom oligonucleotides for applications, such as PCR and oligonucleotide synthesis, is also expected to improve over the forecast period.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Oligonucleotide Synthesis Market Outlook will help companies and investors design strategic landscapes.
Services was the largest segment with a revenue share of 43.47% in 2025.
Horizon Databook has segmented the Brazil oligonucleotide synthesis market based on oligonucleotides, equipment/synthesizer, reagents, services covering the revenue growth of each sub-segment from 2021 to 2033.
The demand for oligonucleotides is expected to surge due to the expansion of the biotechnology and pharmaceutical sectors. The biotech and pharmaceutical industries in Brazil drive the need for custom oligonucleotides in research, diagnostics, and therapeutic applications.
Oligonucleotides are crucial in genetic research, including genomics, transcriptomics, and molecular diagnostics. As scientific research and genetic studies continue to expand, the demand for custom oligonucleotides for applications, such as PCR and oligonucleotide synthesis, is also expected to improve over the forecast period.
Brazil Oligonucleotide Synthesis Market Product Outlook (Revenue, USD Million , 2021-2033)
Oligonucleotides
Equipment/Synthesizer
Reagents
Services
Brazil Oligonucleotide Synthesis Market Application Outlook (Revenue, USD Million , 2021-2033)
PCR Primers
PCR Assays and Panels
Sequencing
DNA Microarrays
Fluorescence In Situ Hybridization (FISH)
Antisense Oligonucleotides
Other Applications
Brazil Oligonucleotide Synthesis Market End Use Outlook (Revenue, USD Million , 2021-2033)
Academic Research Institutes
Diagnostic Laboratories
Pharmaceutical - Biotechnology Companies
Reasons to subscribe to Oligonucleotide Synthesis Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Oligonucleotide Synthesis Market Outlook databook
Our clientele includes a mix of Oligonucleotide Synthesis Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil Oligonucleotide Synthesis Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Brazil Oligonucleotide Synthesis Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Brazil Oligonucleotide Synthesis Market, 2021-2033 (US$M)